These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28801316)

  • 21. Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose.
    Mercadante S; Ferrera P; Adile C; Casuccio A
    J Pain Symptom Manage; 2011 Sep; 42(3):464-9. PubMed ID: 21477977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of fentanyl in the treatment of breakthrough cancer pain: Different biotechnologies, different results and different drug costs.
    Giuliani J; Fiorica F; Sacchetto A; Franceschini G; Vaccari F; Bonetti A
    J Oncol Pharm Pract; 2021 Mar; 27(2):445-447. PubMed ID: 33356990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer breakthrough pain. Indications for rapidly effective opioids].
    Kessler J; Bardenheuer HJ
    Anaesthesist; 2011 Jul; 60(7):674-82. PubMed ID: 21491140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid manufacturer bribed doctors to prescribe fentanyl inappropriately, US says.
    Dyer O
    BMJ; 2016 Dec; 355():i6742. PubMed ID: 27979812
    [No Abstract]   [Full Text] [Related]  

  • 26. Fentanyl Buccal Soluble Film: A Review in Breakthrough Cancer Pain.
    Garnock-Jones KP
    Clin Drug Investig; 2016 May; 36(5):413-9. PubMed ID: 27007271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.
    Núñez-Olarte JM; Alvarez-Jiménez P
    J Pain Symptom Manage; 2011 Dec; 42(6):e6-8. PubMed ID: 22048003
    [No Abstract]   [Full Text] [Related]  

  • 28. Are there cost benefits to fentanyl for breakthrough pain?
    Davis MP
    J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
    [No Abstract]   [Full Text] [Related]  

  • 29. WITHDRAWN: Opioids for the management of breakthrough pain in cancer patients.
    Zeppetella G; Davies AN
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD004311. PubMed ID: 26275024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.
    Perelman M; Leake S
    Ann Pharmacother; 2013 Mar; 47(3):428. PubMed ID: 23463744
    [No Abstract]   [Full Text] [Related]  

  • 31. Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.
    Grassin-Delyle S; Naline E; Devillier P
    Ann Pharmacother; 2013 Mar; 47(3):427-8. PubMed ID: 23463741
    [No Abstract]   [Full Text] [Related]  

  • 32. Fentanyl buccal film. New oral transmucosal form has no advantages in breakthrough pain.
    Prescrire Int; 2013 Oct; 22(142):237. PubMed ID: 24298583
    [No Abstract]   [Full Text] [Related]  

  • 33. Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain.
    Mercadante S; Vellucci R; Cuomo A; Adile C; Cortegiani A; Valle A; Villari P; Casuccio A
    Support Care Cancer; 2015 May; 23(5):1349-54. PubMed ID: 25351457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved patient functioning after treatment of breakthrough cancer pain: an open-label study of fentanyl buccal tablet in patients with cancer pain.
    Davies A; Kleeberg UR; Jarosz J; Mercadante S; Poulain P; O'Brien T; Schneid H; Kress HG
    Support Care Cancer; 2015 Jul; 23(7):2135-43. PubMed ID: 25556611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain.
    Dietrich E; Gums JG
    Ann Pharmacother; 2012 Oct; 46(10):1382-91. PubMed ID: 23012382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comment: intranasal fentanyl spray: a novel dosage form for the treatment of breakthrough cancer pain. Authors' reply.
    Dietrich E; Gums JG
    Ann Pharmacother; 2013 Mar; 47(3):429. PubMed ID: 23463745
    [No Abstract]   [Full Text] [Related]  

  • 37. Population pharmacokinetic meta-analysis of intranasal fentanyl spray as a means to enrich pharmacokinetic information for patients with cancer breakthrough pain.
    Kaessner N; Nave R; Roepcke S; Facius A; Lahu G
    Int J Clin Pharmacol Ther; 2012 Sep; 50(9):665-77. PubMed ID: 22784611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fentanyl citrate sublingual formulation (Vellofent®) for quick BTcP hindering.
    Romualdi P; Candeletti S
    Minerva Med; 2016 Apr; 107(2):114-22. PubMed ID: 27064584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroids as co-analgesics with opioids for cancer pain: a survey of Australian and New Zealand palliative care clinicians.
    Eastman P; Le B
    Intern Med J; 2015 Dec; 45(12):1306-10. PubMed ID: 26444446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fentanyl Buccal Tablet vs. Oral Morphine in Doses Proportional to the Basal Opioid Regimen for the Management of Breakthrough Cancer Pain: A Randomized, Crossover, Comparison Study.
    Mercadante S; Adile C; Cuomo A; Aielli F; Cortegiani A; Casuccio A; Porzio G
    J Pain Symptom Manage; 2015 Nov; 50(5):579-86. PubMed ID: 26303188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.